Tetanus and HIV: A fortuitous association?;Tétanos et VIH: Une association fortuite?

Cahiers Sante

Volumn 18, Issue 3, 2008, Pages 131-134

  Wateba, M I ^a   Diop, S A ^b   Nichols, S ^c   Adjoh, S ^a   Gbadamassi, G ^a   Patassi, A ^a   Tidjani, O ^a  

^a Hospitalier Universitaire de Tokoin   (Togo)

^b Hospitalier Universitaire de Fann   (Senegal)

^c Université de Caroline du Nord   (United States)

Author keywords

Fatality; HIV; Morbidity; Tetanus

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLASSIFICATION; COMPARATIVE STUDY; EVALUATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY; SERODIAGNOSIS; STATISTICAL ANALYSIS; TETANUS;

ADULT; CD4 LYMPHOCYTE COUNT; DATA INTERPRETATION, STATISTICAL; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; TETANUS;

EID: 66749188371     PISSN: 11575999     EISSN: None     Source Type: Journal    
DOI: 10.1684/san.2008.0114     Document Type: Article

References (13)

1. WHO/AFRO. Progress towards materna land neonatal elimination (MNTE) in the African Region. Vaccine Prev Dis Bull 2003; 36: 1-3.
2. Grunitzky BM, Apetoh A, Tidjani O, et al. Tétanos néonatal au CHU de Lomé Tokoin. À propos de 145 cas. Bull Soc Path Exot 1991; 84: 540-9.
3. Rapport d'enquête: recensement des personnes vivant avec le VIH (PVVIH) suivies dans les structures de prise en charge médicale au Togo (1999-2007).
4. Bonetti TC, Succi RC, Weckx LY, et al. Tetanus and diphtheria antibodies and responseto a booster dose in Brazilian HIV-1-infected women. Vaccine 2004; 22: 3707-12.
5. Ndour CT, Soumaré M, Diop BM, et al. Le tétanos à porte d'entrée obstétricale à Dakar: aspects épidémiologiques et pronostiques à propos de 21 cas observés à la clinique des maladies infectieuses du CHU de Dakar. Med Mal Infect 2002; 32: 399-404.
6. Dieye TN, Sow PS, Simonart T, et al. Immunologic and virologic response after tetanus toxoid booster among HIV-1- and HIV-2-infected Senegalese individuals. Vaccine 2001; 20: 905-13.
7. Scott S, Cumberland P, Shulman CE, et al. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis 2005; 191: 1854-60.
8. Rapport de l'OMS 2005. Contrôle, surveillance, planification, financement de la tuberculose dans le monde.
9. Diop Mar I, Sow A, Badiane S, et al. Clinical aspects of tetanus in Africa with 1,019 cases in Dakar (1982-1983). Seventh Intern. Conf. On Tetanus, Copanello (Italy), 10-15 septembre 1984.
10. Seydi M, Soumaré M, Sow PS, et al. Le tétanos: aspects épidémiologiques à la Clinique des Maladies Infectieuses du CHU de Fann à Dakar. Dakar Med 2000; 45(1): 5-7.
11. Vakil BJ, Dalai NJ. Ways of inoculation, portal of entry of tetanus and risk evaluation of a wound. Proceeding of the IVth intern. Conf. on tetanus, Dakar, 1975.
12. Cumberland P, Shulman CE, Maple PA, et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis 2007; 196: 550-7.
13. World Health Organization. Tetanus vaccine. Wkly Epidemiol Rec 2006; 81: 198-208.